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        During innate and adaptive immune responses, 
NK cells and DCs appear to play distinct, com-
plementary, and synergistic roles. NK cells, by 
virtue of their capacity to respond without prior 
sensitization, can directly eliminate infected or 
transformed target cells and elaborate soluble 
factors (cytokines and chemokines) that recruit 
and amplify the infl  ammatory response. DCs, in 
contrast, are the sentinels that, once activated, 
take up antigen, mature, and migrate to second-
ary lymphoid organs, where they present the 
processed antigen to naive T cells to initiate the 
adaptive immune response. In addition, DCs and 
NK cells can interact in a reciprocal fashion that 
results in the mutual activation of both types of 
cells (for review see reference   1  ). Mature DCs 
can prime NK cells to enhance their functional 
capacities (  2  ), whereas activated NK cells se-
crete IFN-      that up-regulates antigen presenta-
tion in DCs and can  “  edit  ”   DC responses through 
the elimination of immature DCs (  3, 4  ). In this 
way, NK cells and DCs represent two highly 
specialized cell types that interact in a comple-
mentary fashion. This cellular strategy could 
provide an additional level of control, because 
complete immune responses would not be effi   -
ciently achieved by activation of either cell type 
in isolation. 
  Recently, the functional dichotomy of DCs 
and NK cells has been challenged with the 
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  Interferon-producing killer dendritic cells (IKDCs) are a recently described subset of 
CD11c  lo  B220     cells that share phenotypic and functional properties of DCs and natural killer 
(NK) cells (Chan, C.W., E. Crafton, H.N. Fan, J. Flook, K. Yoshimura, M. Skarica, D. Brockstedt, 
T.W. Dubensky, M.F. Stins, L.L. Lanier, et al. 2006.   Nat. Med.   12:207–213; Taieb, J., 
N. Chaput, C. Menard, L. Apetoh, E. Ullrich, M. Bonmort, M. Pequignot, N. Casares, M. Terme, 
C. Flament, et al. 2006.   Nat. Med.   12:214–219). IKDC development appears unusual in 
that cytokines using the interleukin (IL)-2 receptor      (IL-2R    ) chain but not those using 
the common      chain (      c  ) are necessary for their generation. By directly comparing 
Rag2      /           c        /y  , Rag2      /     IL-2R          /     , Rag2      /     IL-15      /     , and Rag2      /     IL-2      /      mice, we demonstrate 
that IKDC development parallels NK cell development in its strict IL-15 dependence. 
Moreover, IKDCs uniformly express NK-specifi  c Ncr-1 transcripts (encoding NKp46), 
whereas NKp46     cells are absent in Ncr1  gfp/        c        /y   mice. Distinguishing features of IKDCs 
(CD11c  lo  B220    MHC-II    ) were carefully examined on developing NK cells in the bone mar-
row and on peripheral NK cells. As B220 expression was heterogeneous, defi  ning B220  lo   
versus B220  hi   NK1.1     NK cells could be considered as arbitrary, and few phenotypic differ-
ences were noted between NK1.1     NK cells bearing different levels of B220. CD11c expres-
sion did not correlate with B220 or major histocompatibility complex (MHC) class II 
(MHC-II) expression, and most MHC-II     NK1.1     cells did not express B220 and were thus 
not IKDCs. Finally, CD11c, MHC-II, and B220 levels were up-regulated on NK1.1     cells 
upon activation in vitro or in vivo in a proliferation-dependent fashion. Our data suggest 
that the majority of CD11c  lo  B220       “  IKDC-like  ”   cells represent activated NK cells. 2570 IKDCS ARE ACTIVATED NK CELLS | Vosshenrich et al.
  Considering their curious developmental, phenotypic, and 
functional qualities, we have analyzed the development of 
  “  IKDC-like  ”   cells (the CD11c  lo  B220      subset) using a series of 
C57BL/6 mice defi  cient in selected cytokines and their recep-
tors. Using mice that report expression of the NK cell  –  specifi  c 
NKp46 molecule (Ncr-1  gfp/    mice) (  14  ), we demonstrate that 
IKDC-like cells are developmentally related to NK cells and 
share their IL-15 dependence. Moreover, many of the distin-
guishing features of IKDC-like cells (B220, CD11c, and 
MHC-II expression) are inducible in NK cells. Our results 
challenge the view that IKDC-like cells belong to a separate 
DC lineage but provide evidence that the majority of these 
cells resemble activated NK cells. 
    RESULTS AND DISCUSSION   
  Cells expressing the IKDC-like profi  le are bona fi  de NK cells 
  Cells with the CD11c  lo  B220      phenotype are heterogeneous, 
as both CD11c and B220 are expressed by B, T, and NK 
lymphocytes and by diverse DC subsets. By excluding CD3      
and CD19      cells, the CD11c  lo  B220      subset has been shown to 
contain pDCs (NK1.1        Ly6C     ) and a novel NK1.1     CD49b      
subset called IKDCs (  5, 6  ). Previous reports detected IKDCs 
in Rag2       /             c      −  /y   mice but not in IL-2R            /       mice (  5, 6  ). 
These surprising results suggested the existence of a novel 
  il2rg  -dependent but   il2rb  -dependent signaling pathway that 
promoted IKDC development. Alternatively, the absence of 
IKDCs in IL-2R            /       mice could have resulted from the in-
fl  ammatory syndrome that these mice develop with age (  13  ). 
To address these possibilities, we examined the CD11c  lo  B220      
subset in Rag2       /       mice that were defi  cient or not in the        c   
or IL-2R      chains (  Fig. 1 A  ).   All mice were backcrossed onto 
the C57BL/6 background and carried the   Nkrp1c   B6 allele 
(allowing detection by NK1.1). We found that all mice had 
similar absolute numbers of BM CD11c  lo  B220      cells but that 
the defi  ciency in        c   or IL-2R      completely ablated develop-
ment of NK1.1  +   or CD49b      cells within the CD11c  lo  B220      
subset (  Fig. 1 A  ). Analysis of splenocytes from these mice 
yielded similar results (  Fig. 1 B  ). To determine which IL-
2R       –  dependent ligand was driving IKDC development, we 
further analyzed Rag2       /      IL-2       /       and Rag2       /      IL-15       /       
mice. The CD11c  lo  B220     NK1.1  +   subset was present in 
the former but not the latter (Fig. S1, available at http://www
.jem.org/cgi/content/full/jem.20071451/DC1), confi  rming 
the essential role for IL-15 in the development of all NK1.1      
cells (  15  ). 
characterization of a hybrid cell subset called IFN-producing 
killer DCs (IKDCs) (  5, 6  ). IKDCs were characterized as 
CD3        CD19         cells with a CD11c  lo  B220      phenotype and 
were clearly distinguished from plasmacytoid DCs (pDCs) 
because of the absence of Ly6C (Gr-1) expression (  5  ). 
CD11c  lo  B220     Gr-1    −    cells expressed NK1.1 and CD49b in 
addition to other NK cell surface markers (NKG2D and Ly49 
family receptors), and like DCs, they expressed co-stimula-
tory molecules (CD80 and CD86) and MHC class II (MHC-II) 
(  5, 6  ). Moreover, initial reports demonstrated that IKDCs 
possess NK cell  –  like cytotoxicity and inducible IFN-      pro-
duction, as well as a DC-like ability to secrete IFN-      and to 
stimulate transgenic OVA-specifi  c T cells (  5, 6  ). Based on 
these observations, IKDCs appear to represent a hybrid eff  ec-
tor cell that can act both as the   “  assassin  ”   (NK cells) and as the 
  “  messenger  ”   (DCs). 
  Although the evidence for dual IKDC function was 
clearly demonstrated at the population level (i.e., in the 
CD11c  lo  B220      subset), it could not be rigorously ruled out 
that IKDC activities were simply the additive property of 
two distinct cell types that shared a CD11c  lo  B220      pheno-
type. Neither CD11c nor B220 are DC-specifi  c markers, as 
B cells express B220 and activated B cells and CD8 T cells, 
and most NK cells were shown to express CD11c (  7  –  10  ). 
Only a minor fraction of IKDCs was able to produce type I 
IFN upon stimulation in vitro (  5  ), and direct evidence that 
the same cell can produce both IFN-      and IFN-      is still 
lacking. Moreover, recent reports have challenged the idea 
that IKDCs secrete IFN-      upon stimulation (  11, 12  ), sug-
gesting that minor pDC contamination in IKDC purifi  ca-
tion may have accounted for the type I IFN detected in a 
previous report (  5  ). 
  Concerning their development from hematopoietic pre-
cursors, IKDCs appeared to have a truly unique cytokine de-
pendency, because they were not detected in mice lacking 
the IL-2R      chain (required for IL-2 and IL-15 receptor 
function), whereas they were present in mice lacking the 
common       chain (       c  ; required for IL-2, -4, -7, -9, -15, and -21 
receptors) (  5, 6  ), suggesting the existence of a new IL-2R       – 
dependent,        c  -independent signaling pathway. Alternatively, 
IKDCs could also be IL-2R      independent but might be missing 
from IL-2R            /       mice secondary to the intense infl  amma-
tory syndrome that these mice develop (  13  ). Lastly, genetic 
background diff  erences in the mice analyzed could explain 
the divergent results. 
  Figure 1.     NK1.1    CD11c  lo  B220     (IKDC-like) cells are NK cells. (A) Analysis of BM cells from Rag2      /      (top row), Rag2      /    IL-2R        /      (middle  row), 
and Rag2      /        c      /y   (bottom row) mice. CD11c versus B220 profi  les of BM cells from the indicated mice (left) with gates for cDCs (dotted line) and pDCs 
(continuous line) with their absolute cell numbers are given. (middle and right) NK1.1 and CD49b histograms, respectively, of the gated CD11c  lo B220     cells 
from the left. The percentages of NK1.1     (middle) and CD49b     (right) cells among gated CD11c  lo B220     cells are indicated. (B) Analysis of splenocytes from 
the same mice as in A. Shown are population overlays of viable cells (gray) with NK1.1    CD49b     cells (blue). (C) Analysis of   ncr1  gfp/      c   /     and   ncr1  gfp/      c   − /y   
mice. (left) CD11c versus B220 profi  le of gated CD3       CD19        splenocytes of the indicated mice. (middle) PDCA-1 versus NK1.1 profi  les on gated 
CD11c  lo B220     cells. (right) GFP fl  uorescence (NKp46 expression) on gated NK1.1      and  PDCA-1     cells. (D) NK1.1 versus CD49b profi  le of BM cells from the 
same mice as in A. (left) The gates indicate CD49b    NK1.1  −    (red) and NK1.1      (blue) cells, respectively, and the absolute cell numbers are indicated. 
(right) A population overlay of the gated populations for CD11c versus B220 expression. The results shown are representative of two to three animals per genotype.   
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(PMA plus ionomycin), we found that CD11c      or B220      
NK cells produced somewhat more IFN-      than CD11c         or 
B220         NK cells (  Fig. 2 C  ). Collectively, these results fail to 
support the notion that B220  hi   cells represent a distinct pheno-
typic and functional NK1.1      NK cell subset. 
  Activation-induced changes in B220, CD11c, and MHC-II 
expression in NK cells 
  MHC-II expression has been proposed as a defi  ning charac-
teristic for CD11c  lo  B220  +   IKDC-like cells (  5  ). Consistent with 
a previous report (  5  ), few splenic NK cells (CD3    −   NK1.1     ) 
from C57BL/6 mice expressed MHC-II molecules on their 
cell surface under steady-state conditions (  Fig. 3 A  ).   The 
highest proportion of MHC-II  +   cells among CD3        NK1.1      
cells could be detected in the lymph nodes (10  –  50%), al-
though a subset of MHC-II      NK cells in the BM was detected 
(  Fig. 3 A  ). Surprisingly, only a minority of MHC-II  +   NK cells 
coexpressed B220, and in the tissues examined, MHC-II and 
B220 expression on NK cells was not correlated in an obvious 
fashion (  Fig. 3 A  ). Similar results were obtained when examining 
coexpression of B220 and CD86 on NK cells (unpublished 
data). These results argue against the existence of a widely 
distributed IKDC-like NK1.1      cell that coexpresses B220 
and MHC-II (  5, 6  ). 
  The low frequency of MHC-II      NK cells might refl  ect 
the steady-state, noninfl  ammatory situation in normal, healthy 
mice. We next analyzed whether infl  ammatory stimuli would 
modify the NK cell phenotype in vivo. Mice were injected 
with either poly I:C (a Toll-like receptor [TLR] 3 ligand) or 
CpG ODN (a TLR9 ligand), and 3 d later, CD3        NK1.1      
cells were analyzed for CD11c, MHC-II, and B220. CD11c 
levels increased dramatically on NK cells from the BM, spleen, 
and lymph nodes after TLR activation (  Fig. 3 B  ). Concur-
rently, most NK cells up-regulated B220 expression. As a result, 
    30  –  50% of NK cells from poly I:C  –   or CpG ODN  –
  treated mice became IKDC-like (  Fig. 3 B  ). The increase in 
CD11c     B220      NK cells was likely caused by up-regulation of 
these markers rather than by preferential proliferation of 
CD11c  lo  B220     NK1.1  +   cells, because Ki67 expression (a marker 
of cells undergoing cell division) was predominantly found in 
NK1.1     B220  neg   cells (unpublished data). Interestingly, MHC-II 
expression was increased on all NK cells in mice treated with 
CpG ODN but only in lymph node NK cells in mice receiving 
poly I:C treatment (  Fig. 3 C  ), suggesting a diff  erential thresh-
old for induction of MHC-II on NK cells after activation 
in this tissue. As for the case with resting NK cells (  Fig. 3 A  ), 
no direct correlation could be made with inducible MHC-II 
expression in NK cells expressing diff  erent levels of B220 (not 
depicted). These results suggested that CD11c, B220, and 
MHC-II behave as classical activation markers on NK cells, 
although their inducible expression is diff  erentially controlled. 
Finally, increased CD86 expression paralleled inducible MHC-II 
expression (unpublished data). Collectively, these results show 
that mouse NK cells appear to closely resemble human NK cells 
in their inducible expression of MHC-II and co-stimulatory 
molecules (  20  ). 
  NKp46 is an NK cell  –  specifi  c receptor expressed in human, 
bovine, and mouse NK cells encoded by the   Ncr-1   gene (  14, 
16  –  18  ). Mice expressing GFP under Ncr-1 transcriptional con-
trol elements show strong GFP fl  uorescence in CD3        NK1.1      
cells (  14, 18  ). Using Ncr-1  gfp/    mice (  14  ), we found that two 
cell types were present in the CD3        CD19    −   CD11c  lo  B220  +   
subset: the fi  rst consisted of pDCs that expressed the pDC anti-
gen 1 (PDCA-1) marker, whereas the second included the 
putative IKDCs expressing NK1.1 (  Fig. 1 C  ). Remarkably, the 
CD11c  lo  B220     NK1.1      subset highly expressed NKp46 (also 
confi  rmed by cell-surface staining; unpublished data), indicat-
ing that IKDC-like cells were more closely related to NK cells 
than previously anticipated. Moreover, NKp46 expression was 
completely eliminated when Ncr-1  gfp/    mice were made defi  -
cient in        c   (  Fig. 1 C  ). NKp46 expression was not detected in 
pDCs (  Fig. 1 C  ) or conventional DCs (cDCs; not depicted) 
under any condition. 
  A recent report indicated that IKDCs in        c  -defi  cient mice 
diff  ered from IKDCs in C57BL/6 mice in that they were 
NK1.1         but expressed CD49b (  19  ). We therefore studied the 
NK1.1        CD49b      cells that were equally present in the BM of 
Rag2       /      , Rag2       /  −   IL-2R            /      , and Rag2       /             c         /y   mice (  Fig. 
1 D  ). Compared with NK1.1     CD49      cells (of which a fraction 
expressed the CD11c lo  B220      phenotype), NK1.1       CD49b      
cells lacked CD11c and B220 expression (  Fig. 1 C  ). Thus, 
NK1.1      cells with the CD11c  lo  B220      phenotype (IKDC-like 
cells) require IL-15 for their development and express NKp46; 
these are characteristics of bone fi  de NK cells. 
  B220 expression on developing and mature NK cells 
  We studied further the expression of B220 by cells of the NK 
cell lineage. NK cell precursors were essentially B220        , 
whereas a minor population of immature NK cells were B220  lo   
(  Fig. 2 A  ).   In contrast,     10-30% of mature NK1.1     CD49b      
NK cells in the BM and spleen clearly expressed B220 in a 
rather homogeneous fashion (  Fig. 2, A and B  ). Because B220 
expression on peripheral NK cells was not bimodal, we con-
sider it arbitrary to designate B220         versus B220      NK cell 
subsets, as others have done (  5, 6  ). Examining the phenotypes of 
NK1.1      cells bearing low versus high levels of B220 (  Fig. 2 B  ), 
the frequency of NK cells expressing Ly49 receptors (A, C/I, 
G2, or D) or CD94 was not substantially diff  erent. B220      NK 
cells were uniformly CD62L  hi   and had slightly higher expres-
sion of CD11c (  Fig. 2 B  ), although CD11c expression was not 
bimodal. In contrast, the overall density of CD11b was re-
duced on B220      NK cells. No diff  erences in the expression of 
NKG2D, CD49b, and CD44 were found between B220         and 
B220      NK cells (unpublished data). 
  Previous reports have demonstrated that B220      NK cells 
have enhanced functional activities compared with B220         
NK cells (  5, 6  ). We found that both B220         and B220      NK 
cells were similarly capable of IFN-      production after stimu-
lation in vitro with IL-2 and IL-12 or IL-2 and CpG oligo-
deoxynucleotide (ODN;   Fig. 2 C  ). Moreover, IFN-      
production did not correlate with CD11c expression (  Fig. 2 C  ). 
However, when stimulated with pharmacological agents JEM VOL. 204, October 29, 2007  2573
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  Figure 2.     Phenotype and function of B220         and B220     NK cells. (A) B220 expression on BM NK cell precursors (CD122    NK1.1      CD49b      ;  left), 
immature NK cells (CD122    NK1.1   CD49b       ; middle), and mature NK cells (CD122    NK1.1   CD49b    ; right) from Rag2      /      mice. (B) Splenocytes from 
Rag2      /      mice analyzed for NK1.1 and B220 expression. (top left) The distribution of NK1.1      cells expressing B220 and the gating for B220   −    and  B220    
NK cells. (bottom left) Histogram shows the B220 expression on the same gated NK1.1      cells. The range of percentages of B220      cells among total 
NK1.1      cells is given (  n   = 10). The remaining histograms show overlays of CD11c, CD11b, CD62L, and CD94 (top, from left to right) and Ly49C/I, Ly49A, 
Ly49G2, and Ly49D (bottom, from left to right) expressed by B220    NK1.1 +   cells (continuous line) and B220       NK1.1 +   cells (shaded) from Rag2      /      spleno-
cytes. (C) Expression of IFN-      in  NK1.1 +   cells in relation to B220 expression (top) and CD11c expression (bottom). NK cells above the horizontal bar 
are B220      (top) or CD11c  +   (bottom), and the red numbers indicate the percentage of IFN-         cells among total B220      or  CD11c     NK1.1     cells,  respec-
tively. The cells below the horizontal bar are B220   −    (top) or CD11c         (bottom), and the blue numbers indicate the percentage of IFN-         cells in total 
B220         or CD11c         NK1.1     cells, respectively. The results shown are representative of two to three experiments. iNK, immature NK cell; mNK, mature NK 
cell; NKP, NK cell precursor.     2574 IKDCS ARE ACTIVATED NK CELLS | Vosshenrich et al.
  Figure 3.     Activation-induced expression of B220, CD11c, and MHC-II by NK1.1     cells. (A) MHC-II versus B220 expression (red) of gated 
CD3       CD19  −  NK1.1     BM (left), spleen (middle), and lymph node (right) cells from C57BL/6 mice. The blue staining represents the isotype control for the 
anti  –  MHC-II antibodies. (B) Population overlays of NK1.1      cells (blue) on CD11c versus B220 dot plots of total cells (gray) from the BM (left), spleen 
(middle), and lymph nodes (right) harvested from Rag2      /      mice injected with PBS (top row), CpG ODN 1668 (middle row), or poly I:C (bottom row). JEM VOL. 204, October 29, 2007  2575
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was accompanied by an increase in B220 expression (a two-
fold increase in mean fl  uorescence intensity). By days 3 and 4, 
a clear fraction of NK cells had further proliferated, and their 
B220 expression was approximately fi  vefold higher than that 
observed on NK cells at the start of the culture. Similar results 
were obtained in IL-2  –  supplemented cultures of lymph node  –   
or thymus-derived NK cells (  Fig. 4 A   and not depicted).   All 
IL-2  –  cultured NK cells demonstrated increased expression of 
NK1.1, CD11c, and B220 (unpublished data), suggesting that 
  NK cell proliferation increases B220 expression in vitro 
and in vivo 
  To understand the mechanisms and dynamics of inducible 
B220 expression by NK1.1      cells, we labeled total splenocytes 
from Rag2       /       mice with CFSE and cultured them in IL-2. 
B220 expression on NK1.1      cells was analyzed daily in rela-
tion to cytokine-induced proliferation. During the fi  rst 2 d, 
most NK cells divided asynchronously, as indicated by the 
even dilution of CFSE in the bulk NK cell population, which 
(C) Expression of MHC-II molecules by B220    NK1.1     (red) and B220   −  NK1.1     (blue) cells from the same mice and organs analyzed in B. Shaded histo-
grams represent isotype control staining by NK1.1      cells from the respective mice and organs. The results shown are representative of three to 
fi   ve  experiments.   
    
   
  Figure 4.     Dynamic B220 expression by NK1.1     cells. (A) Total CFSE-labeled splenocytes from Rag2      /      mice were cultured with IL-2. At the indicated 
times, cells were harvested and analyzed for B220 expression. The values of mean fl  uorescence intensity (MFI) indicate the expression level of B220 at the cell 
surface of the NK1.1     cells analyzed. (B) Expression of B220 by sorted B220      (shaded) or B220   −    (continuous line) NK1.1    CD49b     cells from Rag2      /      mice 
after 7 d of culture in IL-2. The results shown are representative of three experiments. (C, left) The dot plot indicates the gates used to sort B220       NK1.1     cells 
(left gate) and B220    NK1.1     cells (right gate) from Rag2      /      mice. The sorted cells were adoptively transferred into NK cell  –  profi  cient (Rag2      /     ) or NK cell  –
 defi  cient (Rag2      /    IL-2R        /     ) hosts. Some of the NK cell  –  profi  cient hosts receiving B220       NK1.1     cells were injected with poly I:C at the day of transfer. 
(middle) CFSE dilution of NK1.1     cells 3 d after transfer of B220         (top) and B220      (bottom) cells into the indicated hosts. (right) The histograms show the 
expression levels of B220 by the transferred cells 3 d after the transfer, as indicated. The colors in the histograms match the populations defi  ned by the 
dashed ovals in the middle panels. The results shown are representative of two to fi  ve animals per group from two to three experiments.    2576 IKDCS ARE ACTIVATED NK CELLS | Vosshenrich et al.
  T cell stimulatory activity of B220     and B220        NK cells 
  Peptide-pulsed CD11c  lo  B220     NK1.1  +   cells were reported to 
stimulate antigen-specifi  c T cells (  5  ), suggesting that IKDCs 
could function as APCs to stimulate adaptive immune re-
sponses. We next assessed whether T cell stimulatory activity 
was a unique property of B220      NK cells.   “  Marilyn  ”   TCR-
transgenic cells specifi  c for the male antigen Dby presented by 
I-A  b   (  24  ) were used as responder cells. Female Rag2       /       mice 
were injected with CpG ODN, and 3 d later, B220      NK 
cells, B220         NK cells, pDCs, and cDCs were isolated. Cells 
were pulsed with the Dby peptide, and pulsed and nonpulsed 
cells were cultured with sorted, CFSE-labeled Marilyn T cells. 
After 5 d, T cell proliferation was assessed by CFSE dilution. 
Both B220      and B220         NK cells were able to stimulate 
division of     30% of Marilyn CD4      T cells (  Fig. 5  ).   Never-
theless, CpG-activated NK cells were clearly less effi   cient 
than either pDCs or cDCs in their T cell stimulatory capacity. 
This result contrasts with a previous study that demonstrated 
B220      NK cells to be more effi   cient than pDCs in T cell 
stimulation (  5  ). The diff  erence may lie in the choice of a TCR-
transgenic mouse model (OT-II vs. Marilyn) that may diff  er in 
activation threshold. 
  Conclusions 
  In this report, we provide evidence that NK1.1      cells with the 
CD11c  lo  B220      phenotype (IKDC-like cells) are bona fi  de 
NK cells. All CD3        NK1.1  +   cells share the same developmental 
requirements (       c  , IL-2R     , and IL-15) and express the same 
NK cell  –   specifi  c genes (NKp46). These features clearly dis-
tinguish NK cells from diverse DC subsets. 
  We also demonstrate inducible B220 and CD11c expres-
sion after NK cell activation in vitro and in vivo. The capacity 
of NK cells to express high levels of CD11c after activation 
in vivo might explain the increased frequency of intratumoral 
CD11c     NK1.1      cells detected in patients treated with ima-
tinib mesylate and IL-2, as reported by Taieb et al. (  6  ). Simi-
larly, their activated status would explain why B220     NK1.1  +   
cytokine-induced proliferation can generate an IKDC-like 
phenotype from resting NK cells. 
  To study whether B220         NK cells can up-regulate this 
protein after activation, we sorted splenic B220      and B220    −    
NK cells (NK1.1     CD49b     ) from Rag2    −  /  −    mice and cultured 
them with IL-2. At day 7, we found that all NK cells from the 
sorted B220         population now expressed B220 at the cell surface 
at levels similar to the sorted B220      population (  Fig. 4 B  ). 
  To further investigate the proliferation-induced B220 
expression on NK cells, we purifi  ed splenic B220    −    and B220    
NK1.1      cells from Rag2    −  /  −    mice, labeled them with CFSE, 
and adoptively transferred them into NK cell  –  defi  cient Rag2    −  /     
IL-2R         −  /  −    recipient mice. The analysis of CD11c expression 
by the sorted B220    −    and B220      NK cells confi  rmed that 
both populations expressed CD11c, with B220      NK cells ex-
pressing slightly higher CD11c levels (Fig. S2, available at 
http://www.jem.org/cgi/content/full/jem.20071451/DC1). 
Both NK cell populations underwent   “  homeostatic  ”   prolifera-
tion (  21  –  23  ) based on their CFSE-dilution profi  les. Although 
B220  +   NK cells maintained B220 expression, the B220    −    NK 
cells became B220  +   (  Fig. 4 C  ). We next assessed whether B220 
induction on B220    −    NK cells was proliferation dependent by 
transferring CFSE-labeled B220    −    and B220      NK cells into NK 
cell  –  profi  cient (B    −   , T    −   , and NK     ) Rag2    −  /  −    recipients. Most 
transferred NK cells did not divide in these hosts (  Fig. 4 C  ), 
likely because of competition with endogenous NK cells for 
cellular resources such as IL-15 (  22  ). Under these conditions, 
B220    −    NK cells remained B220        , whereas B220      NK cells 
maintained B220 expression (  Fig. 4 C  ). Lastly, we assessed the 
eff  ects of TLR engagement on the fate of adoptively trans-
ferred B220         NK cells in Rag2       /       recipients. In contrast to 
untreated Rag2       /  −    mice, B220         NK cells proliferated in 
poly I:C  –  treated Rag2       /       recipients, with concomitant up-
regulation of B220 expression (  Fig. 4 C  ). Thus, B220 expression 
is up-regulated on proliferating NK cells in vivo. These results 
suggest that TLR ligands may modify NK cell activation states 
through stimulation of NK cell proliferation. 
  Figure 5.     T cell stimulatory potential of NK1.1     NK cells is independent of B220 expression. Sorted B220       NK1.1     cells,  B220   NK1.1     cells,  pDCs, 
and cDCs from CpG ODN 1668     treated mice (3 d before the sort) were incubated with the MHC-II  –  restricted H-Y peptide Dby and co-cultured with sorted, 
CFSE-labeled V    6   CD4     T cells from Marilyn TCR transgenic mice. 3 d later, cells were harvested and analyzed for the CFSE dilution. The percentages of cells 
having undergone one or more cell divisions are indicated. Sorted B220       NK1.1     cells,  B220   NK1.1     cells, pDCs, and cDCs that were not incubated with the 
Dby peptide failed to stimulate proliferation of Marilyn T cells (not depicted). The results shown are representative of two animals per group.     JEM VOL. 204, October 29, 2007  2577
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cells isolated from these patients exhibit an increased func-
tional competence in vitro and in vivo (  6  ). Other markers 
suggested to be specifi  c for CD11c  lo  B220     NK1.1      cells, such 
as MHC-II and CD86, were clearly not confi  ned to these 
cells but were also expressed by B220  lo/  −    NK cells in naive 
mice. Some of these activation-induced phenotypic changes 
(acquisition of B220) are closely linked to cellular prolifera-
tion. Up-regulation of B220 and CD11c has been previously 
detected on activated NK T cells and CD8  +   T cells (  10, 25  ). 
As such, these   “  atypical  ”   markers may signal recent cytokine 
stimulation, thereby representing a conserved mechanism that 
operates in cytotoxic cells. 
  MATERIALS AND METHODS 
  Mouse strains.     Mice defi  cient in   Rag2   (  Rag2       /        ) and its derivatives defi  -
cient in        c   (  Rag2       /  −          c         /y      ), in the IL-2R      chain (  Rag2       /      IL-2R            /          ; pro-
vided by S. Koyasu, Keio University, Tokyo, Japan), in IL-2 ( Rag2       /  −   IL-2       /        ), 
or in IL-15 (  Rag2       /      IL-15       /        ) on the C57BL/6 background have been 
previously described (  15, 26  ). Mice carrying a GFP reporter in the NK 
cell  –  specifi  c Ncr-1 locus (  Ncr1  gfp/     ) have been previously described (  14  ), 
and male   Ncr1  gfp/      mice were crossed to female   Rag2       /            c         /           mice to create 
       c  -defi  cient   Ncr1  gfp/      male mice. C57BL/6 mice were obtained from Charles 
River Laboratories. Mice were maintained in specifi  c pathogen-free condi-
tions at the Institut Pasteur and were used at 4  –  10 wk of age. Mouse experi-
ments were approved by an institutional committee at the Institut Pasteur 
and validated by the French Ministry of Agriculture. 
  Antibodies and reagents.     mAbs directly conjugated to FITC, PE, PE-
Cy7, PerCP-Cy5.5, PE-Cy5.5, allophycocyanin, allophycocyanin-Cy7, or 
biotin specifi  c for the following antigens (clone name in parenthesis) were 
used: B220 (RA3-6B2), CD3 (145-2C11), CD11b (M1/70), CD11c (N418 
and HL3, respectively), CD19 (1D3), CD49b (DX5), CD62L (MEL14), 
CD86 (GL1), CD94 (18d3), CD122 (TM-     1), I-A/I-E (M5/1 14.15.2), 
Ly49A (JR9), Ly49G2 (4D11), Ly49C/I (5E6), NK1.1 (PK136), PDCA-1 
(PDCA-1), and IFN-      (XMG1.2). Antibodies were purchased from Becton 
Dickinson, eBioscience, Biolegend, and Miltenyi Biotec. The polyclonal goat 
anti  –  mouse anti-NKp46 serum was purchased from R  &  D Systems. FCS and 
PBS were purchased from Invitrogen. 
  Isolation of lymphoid cells and fl  ow cytometric analysis.     Single-cell 
suspensions from the BM, spleen, lymph nodes, and thymus and FACS anal-
ysis were performed using a fl  ow cytometer (FACSCanto or FACSCanto II; 
Becton Dickinson) with FACSDiva software (5.02; Becton Dickinson), as 
previously described (  27  ). Datasets were analyzed using FlowJo software 
(Tree Star, Inc.). Cell sorting was performed on a cell sorter (FACSAria, BD 
Biosciences; access was provided by the Flow Cytometry Platform at the 
  Institut Pasteur). 
  Adoptive transfer of sorted NK cell subpopulations.     Splenic cell sus-
pensions from Rag2       /  −    mice were sorted as NK1.1  +  CD49b  +  B220      or 
B220         cells and injected i.v. into alymphoid recipients. At the given times 
after transfer (as shown in the fi  gures), splenic lymphocytes were prepared, 
and their phenotype was determined. Alternatively, cells were labeled with 
CFSE after sorting, injected i.v. into Rag2       /       or Rag2       /      IL-2R            /       mice, 
and analyzed 3 d later. 
  In vitro cultures.     Splenic cell suspensions from Rag2       /       mice were labeled 
with 5      m CFSE, and 1  –  2       10  5   cells per 200      l were cultured in fl  at-bottom 
microtiter plates in 1,000 U/ml IL-2 (PeproTech). For co-cultures of Marilyn 
T cells with NK cells or IKDC-like cells, we sorted NK1.1  +  B220    −    and 
NK1.1  +  B220  +   cells from female Rag2       /       mice and incubated half of the 
sorted cells with 100 nM Dby peptide. 2       10  4   of the sorted cells were cultured 
with CFSE-labeled V     6  +  CD4  +   T cells from Marilyn Rag2       /       transgenic 
mice (  28  ) at a 1:1 ratio. As controls, we co-cultured Marilyn T cells with 
sorted NK1.1  +  B220         and NK1.1     B220  +   cells that had not been incubated 
with peptide, and with sorted pDCs and cDCs from the same female Rag2       /       
mice. CpG ODN  –  activated cells were obtained from Rag2       /       mice that 
received 35      g CpG ODN (i.p.) 3 d earlier. 
  In vivo activation.     Rag2       /       or C57BL/6 mice were injected i.p. with ei-
ther CpG ODN 1668 (S-oligo; Sigma-Proligo) or poly I:C (Sigma-Aldrich). 
At the time points indicated in the fi  gures, cells from the indicated organs 
were isolated and analyzed. 
  Online supplemental material.    Fig. S1 shows an overlay of NK1.1 +  CD49b  +   
NK cells on a CD11c versus B220 dot plot of viable BM cells derived from 
Rag2    −  /  −   , Rag2    −  /  −   IL-2    −  /  −   , and Rag2    −  /  −   IL-15    −  /  −    mice. Fig. S2 shows the 
expression of B220 and CD11c by sorted B220  +   and B220    −   NK1.1  +  CD49b  +   
splenocytes from Rag2    −  /  −    mice. Online supplemental material is available at 
http://www.jem.org/cgi/content/full/jem.20071451/DC1. 
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